Search results for: 'maximum and acquisition deaf of 2004'
- Did you mean
- maximum and acquisitions deal of 2004
- Related search terms
- Acquisition Terms and Agreements in Pharma
- deaf+on+defend
- deaf+on+demand
- deaf+data+0
- deaf+teva+and+benchmarking
-
Sepsis Diagnostics: Market Forecasts by Assay, Cause, Product, Place and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Sepsis Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Cell Therapy Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cell Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Psychiatry Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Psychiatry Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Metabolic Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Current Partnering Knowledge CenterApril 2026$14,995.00The Leading Partnering Intelligence Platform for Pharma, Biotech and Diagnostic Dealmakers
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Gene Therapy Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Gene Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
